Alnylam Pharmaceuticals, Inc.

STRS OHIO ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

28,036

Value ($000)

11,149

Weight

0.0%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	11,149	0.0%	28,036	12/31/2025
2025 Q3	10/30/2025	12,761	0.0%	27,985	9/30/2025
2025 Q2	8/4/2025	9,828	0.0%	30,140	6/30/2025
2025 Q1	5/28/2025	7,781	0.0%	28,817	3/31/2025
2024 Q4	5/28/2025	5,883	0.0%	25,000	12/31/2024
2024 Q3	11/1/2024	8,105	0.0%	29,468	9/30/2024
2024 Q2	8/5/2024	6,075	0.0%	25,000	6/30/2024
2024 Q1	5/13/2024	3,736	0.0%	25,000	3/31/2024
2023 Q4	1/30/2024	4,785	0.0%	25,000	12/31/2023
2023 Q3	10/26/2023	4,427	0.0%	25,000	9/30/2023
2023 Q2	7/31/2023	5,698	0.0%	30,000	6/30/2023
2023 Q1	4/27/2023	907	0.0%	4,528	3/31/2023
2022 Q4	1/26/2023	861	0.0%	3,623	12/31/2022
2022 Q3	10/27/2022	662	0.0%	3,311	9/30/2022
2022 Q1	4/21/2022	863	0.0%	5,291	3/31/2022
2021 Q4	1/24/2022	218	0.0%	1,291	12/31/2021
2021 Q3	10/22/2021	243	0.0%	1,291	9/30/2021
2021 Q2	7/26/2021	218	0.0%	1,291	6/30/2021
2021 Q1	4/23/2021	609	0.0%	4,320	3/31/2021
2020 Q4	1/25/2021	580	0.0%	4,470	12/31/2020
2020 Q3	12/14/2020	1,680	0.0%	11,539	9/30/2020
2020 Q2	7/23/2020	1,769	0.0%	11,948	6/30/2020
2020 Q1	4/23/2020	424	0.0%	3,902	3/31/2020
2019 Q4	1/24/2020	122	0.0%	1,067	12/31/2019
2014 Q1	4/28/2014	913	0.0%	13,600	3/31/2014
2013 Q4	1/30/2014	875	0.0%	13,600	12/31/2013